EDNRA Forms a Positive Feedback Loop with the Hippo/YAP Axis to Drive Triple‐Negative Breast Cancer Progression
Advanced Science · 2026-10 · 13 (58)
DOI: 10.1002/advs.76784 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.07.2026. Verfasst von Zehao Hong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Receptor, Endothelin A, Transcription Factors, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sustained Hippo/Yes‐associated protein (YAP) activation drives triple‐negative breast cancer (TNBC), but druggable upstream regulators remain unclear. We investigated G protein‐coupled receptors (GPCRs) as membrane inputs for YAP activation. TCGA‐based Hippo/YAP signature analysis, marketed‐drug GPCR annotation, and siRNA screening using connective tissue growth factor (CTGF) identified endothelin receptor type A (EDNRA). EDNRA function was tested by knockdown, overexpression, endothelin‐1 (ET‐1) stimulation, and atrasentan blockade in TNBC cells and xenografts. YAP regulation was examined by immunoblotting, RT‐qPCR, TEAD reporter assays, subcellular localization, docking, co‐immunoprecipitation, mutagenesis, ChIP‐qPCR, and CRISPRi. EDNRA correlated with Hippo/YAP signatures, adverse clinical features, and poor outcome. EDNRA depletion or atrasentan suppressed proliferation, migration, stem‐like populations, and xenograft growth, whereas EDNRA overexpression or ET‐1 had opposite effects. Mechanistically, EDNRA reduced YAP Ser127 phosphorylation, promoted nuclear YAP accumulation, and enhanced TEAD transcription through Gαq/11–Rho/ROCK–LATS signaling. Mutating predicted EDNRA–Gαq/11 interface residues impaired YAP activation and tumor‐promoting activity. Reciprocally, YAP/TEAD4 enhanced EDNRA transcription through an enhancer‐associated region. Atrasentan also sensitized TNBC cells to paclitaxel and produced positive zero interaction potency (ZIP) synergy scores. EDNRA establishes a druggable positive feedback loop with Hippo/YAP signaling and represents a potential therapeutic vulnerability in YAP‐driven TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Cancer Research Institute, The Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region, China.
- Department of Public Health, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
ORCID-Profile: Zehao Hong, Boyang Li, Yi Chen
Zitieren
APA
Hong, Z., Li, B., Xu, J., Lin, R., Pan, J., Fang, C., Zhang, B., Lau, L. Y., Aldridge, R. J., Whitmore, E. A., & Chen, Y. (2026). EDNRA Forms a Positive Feedback Loop with the Hippo/YAP Axis to Drive Triple‐Negative Breast Cancer Progression. Advanced Science, 13(58). https://doi.org/10.1002/advs.76784
Vancouver
Hong Z, Li B, Xu J, Lin R, Pan J, Fang C, et al. EDNRA Forms a Positive Feedback Loop with the Hippo/YAP Axis to Drive Triple‐Negative Breast Cancer Progression. Advanced Science. 2026;13(58). doi:10.1002/advs.76784
BibTeX
@article{Hong2026,
author = {Hong, Zehao and Li, Boyang and Xu, Jiahui and Lin, Ruonan and Pan, Jinghao and Fang, Chenlu and Zhang, Boxiang and Lau, Lucy Yue and Aldridge, Richard J and Whitmore, Elizabeth A and Chen, Yi},
title = {EDNRA Forms a Positive Feedback Loop with the Hippo/YAP Axis to Drive Triple‐Negative Breast Cancer Progression},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {58},
doi = {10.1002/advs.76784}
}
EUVIMED